Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Iga Stukan"'
Autor:
Maria Dąbkowska, Iga Stukan, Bogusław Kowalski, Wiktoria Donerowicz, Monika Wasilewska, Alicja Szatanik, Małgorzata Stańczyk-Dunaj, Aneta Michna
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Biomaterial science has contributed tremendously to developing nanoscale materials for delivering biologically active compounds, enhancing protein stability, and enabling its therapeutic use. This paper presents a process of formation of pol
Externí odkaz:
https://doaj.org/article/820a45b159cc4b67964556e9deacce6b
Autor:
Marcin Cieślak, Julia Kaźmierczak-Barańska, Karolina Królewska-Golińska, Mariola Napiórkowska, Iga Stukan, Urszula Wojda, Barbara Nawrot
Publikováno v:
Biomolecules, Vol 9, Iss 9, p 446 (2019)
We identified novel dicarboximides that were selectively cytotoxic towards human leukemia cells. Using chemical and biological methods, we characterized the biological activity, identified cellular protein targets and defined the mechanism of action
Externí odkaz:
https://doaj.org/article/fbc68bbab05b4cfc9d48c259115ea71c
Autor:
Iga, Stukan, Marek, Gryzik, Grażyna, Hoser, Andrew, Want, Wioleta, Grabowska-Pyrzewicz, Mikolaj, Zdioruk, Mariola, Napiórkowska, Marcin, Cieślak, Karolina, Królewska-Golińska, Barbara, Nawrot, Grzegorz, Basak, Urszula, Wojda
Publikováno v:
Cancers. 14(15)
The search is ongoing for new anticancer therapeutics that would overcome resistance to chemotherapy. This includes chronic myeloid leukemia, particularly suitable for the studies of novel anticancer compounds due to its homogenous and well-known gen
Autor:
Monika Adamowicz, Iga Stukan, Piotr Milkiewicz, Andrzej Bialek, Malgorzata Milkiewicz, Agnieszka Kempinska-Podhorodecka
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4905
Deficient mismatch repair (MMR) proteins may lead to DNA damage and microsatellite instability. Primary sclerosing cholangitis (PSC) is a risk factor for colitis-associated colon cancer. MiR-155 is suggested to act as a key regulating node, linking i
Autor:
Alice Loo, Piotr Stepien, Avery S. Feit, David M. Sabatini, Johann Bergholz, Walter Michael, Monther Abu-Remaileh, Christopher Thomas Brain, Rinath Jeselsohn, Baishan Jiang, Deborah Butter, Michael D. Cameron, Carmine DeAngelis, Wojciech Michowski, Rachel Schiff, Deborah A. Dillon, Karolina Maria Nowak, Iga Stukan, Bojana Jovanovic, Jean J. Zhao, Tobias Otto, Nathanael S. Gray, Maria Ericsson, Anne Fassl, Piotr Sicinski, Ralph Tiedt, Myles Brown, Kornelia Polyak, Qing Sheng
Publikováno v:
Science Advances
This study presents strategies to render triple-negative breast cancers sensitive to CDK4/6 inhibitors.
Inhibitors of cyclin-dependent kinases CDK4 and CDK6 have been approved for treatment of hormone receptor–positive breast cancers. In contr
Inhibitors of cyclin-dependent kinases CDK4 and CDK6 have been approved for treatment of hormone receptor–positive breast cancers. In contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4815f131efc64eea3d77fec1fe579f
http://hdl.handle.net/11588/857297
http://hdl.handle.net/11588/857297
Autor:
Iga Stukan, Barbara Nawrot, Mariola Napiórkowska, Julia Kaźmierczak-Barańska, Karolina Królewska-Golińska, Urszula Wojda, Marcin Cieślak
Publikováno v:
Biomolecules
Volume 9
Issue 9
Biomolecules, Vol 9, Iss 9, p 446 (2019)
Volume 9
Issue 9
Biomolecules, Vol 9, Iss 9, p 446 (2019)
We identified novel dicarboximides that were selectively cytotoxic towards human leukemia cells. Using chemical and biological methods, we characterized the biological activity, identified cellular protein targets and defined the mechanism of action
Autor:
Rolf Lewensohn, Iga Stukan, Merve Kacal, Yi Lai, Kenbugul Jatta, Simon Ekman, Helin Vakifahmetoglu-Norberg, Loránd L. Kis, Per Hydbring, Erik Norberg, Maraam Kanony
Publikováno v:
Biochemical and biophysical research communications. 511(2)
Lung cancer causes the highest number of cancer-related deaths worldwide. Resistance to therapy is a major clinical issue contributing to the poor prognosis of lung cancer. In recent years, targeted therapy has become a concept where subgroups of non